Delivery Order SPE2DB25D3012-SPE2DB25FWWKV

Award Date 3/26/25
Potential Completion Date 4/16/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,679.17 firm fixed-price delivery order is for the supply of the prescription drug XALKORI 250 MG CAPSULE 60S. The contract has an ultimate completion date of May 19, 2023 and was awarded on April 28, 2023. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $12,865.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a performance period through December 6, 2024. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award, valued at $12,679.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is not associated with a set-aside program and was made through full and open competition. The prime contractor, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., a larger pharmaceutical distribution company. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,356.89 firm fixed-price contract is for the supply of XALKORI 250 MG CAPSULE 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of March 18, 2025 and was awarded on February 25, 2025. This delivery order is issued under Amerisourcebergen's existing $999,999,999...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,356.89, is for the delivery of XALKORI 250 MG CAPSULE 60S, a medication used in the treatment of certain types of cancer. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XALKORI 250 MG CAPSULE 60S. The contract has a ceiling value of $12,877.79 and is a firm fixed price delivery order. The ultimate completion date for this contract is October 21, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract, valued at up to $12,877.79, is for the delivery of the prescription drug XALKORI 250 MG CAPSULE 60S. This is a Firm Fixed Price contract with a completion date of May 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 60 capsules of the pharmaceutical product XALKORI 250 MG. The potential value of the contract is $12,877.79, with a completion date of January 30, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader contract vehicle with the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XALKORI 200 MG CAPSULE 60S. The contract has a ceiling value of $14,419.30 and runs through February 4, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract is a firm fixed-price delivery order and was not set...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for $12,877.79 and has a firm fixed price pricing type. It is for the supply of Xalkori 250 mg capsule 60s, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2024 and was awarded on September 25, 2024. It is not a set-aside contract. As one of the largest pharmaceutical...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWWKV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,356.89, is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The contract has an ultimate completion date of April 16, 2025.

Generated 6/29/25, 12:59 AM